TKNO Logo

Alpha Teknova, Inc. (TKNO) 

NASDAQ
Market Cap
$315.05M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
28 of 776
Rank in Industry
1 of 47

Largest Insider Buys in Sector

TKNO Stock Price History Chart

TKNO Stock Performance

About Alpha Teknova, Inc.

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including …

Insider Activity of Alpha Teknova, Inc.

Over the last 12 months, insiders at Alpha Teknova, Inc. have bought $15.16M and sold $0 worth of Alpha Teknova, Inc. stock.

On average, over the past 5 years, insiders at Alpha Teknova, Inc. have bought $8.13M and sold $30,215 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Telegraph Hill Partners IV, L.P. (10 percent owner) — $15M. Gunstream Stephen (President and CEO) — $100,000. Lowell Matthew (Chief Financial Officer) — $49,999.

The last purchase of 12,096,773 shares for transaction amount of $15M was made by Telegraph Hill Partners IV, L.P. (10 percent owner) on 2024‑07‑12.

List of Insider Buy and Sell Transactions, Alpha Teknova, Inc.

2024-07-12Purchase10 percent owner
12.1M
28.4834%
$1.24$15M0.00%
2024-07-12PurchasePresident and CEO
80,645
0.1899%
$1.24$100,0000.00%
2024-07-12PurchaseChief Financial Officer
40,322
0.0949%
$1.24$49,9990.00%
2023-11-30PurchaseChief Commercial Officer
3,587
0.0076%
$1.73$6,220+56.22%
2023-09-19Purchase10 percent owner
8.11M
29.5678%
$1.85$15M+43.58%
2023-09-19Purchasedirector
810,810
2.9568%
$1.85$1.5M+43.58%
2023-09-19PurchasePresident and CEO
54,054
0.1971%
$1.85$100,000+43.58%
2023-09-19PurchaseChief Financial Officer
54,054
0.1971%
$1.85$100,000+43.58%
2023-09-19PurchaseGeneral Counsel and CCO
27,027
0.0986%
$1.85$50,000+43.58%
2023-06-13SaleChief People Officer
11,400
0.0393%
$3.80$43,268-34.02%
2023-05-26Purchase
2,000
0.0069%
$3.21$6,430-18.67%
2023-05-26Purchase
2,000
0.0069%
$3.21$6,430-18.67%
2023-05-17SaleChief People Officer
3,119
0.0107%
$2.04$6,351+31.75%
2023-05-12PurchasePresident and CEO
4,665
0.0141%
$1.67$7,772+42.35%
2023-05-12PurchaseChief People Officer
3,119
0.0094%
$1.67$5,196+42.35%
2023-05-12PurchaseChief Commercial Officer
3,915
0.0118%
$1.67$6,522+42.35%
2022-11-15SaleChief People Officer
2,046
0.0072%
$5.28$10,811-44.40%
2022-11-14PurchasePresident and CEO
1,716
0.0052%
$4.23$7,264-39.76%
2022-11-14PurchaseChief People Officer
2,046
0.0062%
$4.23$8,661-39.76%
2022-11-14PurchaseChief Commercial Officer
1,422
0.0043%
$4.23$6,019-39.76%

Insider Historical Profitability

<0.0001%
Telegraph Hill Partners IV, L.P.10 percent owner
11126929
20.873%
$5.9120
Gunstream StephenPresident and CEO
243497
0.4568%
$5.9160<0.0001%
Lowell MatthewChief Financial Officer
128376
0.2408%
$5.9140<0.0001%
Gelhaus KenChief Commercial Officer
22924
0.043%
$5.9130+1.29%
Davis Irene
1888419
3.5425%
$5.9110<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Millennium Management LLC$4.64M3.441.83M+1.2%+$55,057.86<0.01
Balyasny Asset Management Llc$2.77M1.971.05M0%+$00.01
PLATINUM INVESTMENT MANAGEMENT LTD$1.93M1.37727,761-1.19%-$23,264.350.03
The Vanguard Group$1.05M0.75396,798+0.63%+$6,553.45<0.0001
Parkman Healthcare Partners Llc$784,935.000.56296,202+4.95%+$37,009.890.1
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.